2-Hydroxyethyl methacrylate, >=99%, contains <=50 ppm monomethyl ether hydroquinone as inhibitor

Code: 477028-100ML D2-231

Application

A polymeric hydrogel for drug delivery. Patent has been applied for the development of artificial cornea or KPro, it is composed of pHEMA (polymerized from HEMA) ...


read more

Your Price
£61.00 100ML
£73.20 inc. VAT
REQUEST

Application

A polymeric hydrogel for drug delivery. Patent has been applied for the development of artificial cornea or KPro, it is composed of pHEMA (polymerized from HEMA) and poly (methyl methacrylate)(PMMA). HEMA may be used as a macromonomer for the synthesis of 2-hydroxyethylmethacrylate-poly(ε-caprolactone) (HEMA-PCL) by coordinated anionic ring opening polymerization (ROP).

General description

2-Hydroxyethyl methacrylate (HEMA) is biocompatible in nature. Polymeric hydrogel scaffold can be produced by polymerizing HEMA in water.

Packaging

25, 100 mL in poly bottle

assay≥99%
bp67 °C/3.5 mmHg (lit.)
contains≤50 ppm monomethyl ether hydroquinone as inhibitor
density1.073 g/mL at 25 °C (lit.)
InChI keyWOBHKFSMXKNTIM-UHFFFAOYSA-N
InChI1S/C6H10O3/c1-5(2)6(8)9-4-3-7/h7H,1,3-4H2,2H3
Quality Level200
refractive indexn20/D 1.453 (lit.)
SMILES stringCC(=C)C(=O)OCCO
storage temp.2-8°C
vapor density5 (vs air)
vapor pressure0.01 mmHg ( 25 °C)
Code
Description
Unit Size
List Price
Qty
477028-25ML
2-Hydroxyethyl methacrylate, >=99%, contains <=50 ppm monomethyl ether hydroquinone as inhibitor

Unit:25ML
List Price: £54.30
Source:List Price
ADD
Cas Number868-77-9
This product has met the following criteria: